# Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-treatment-with-rituximab-for-difficult-steroid-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ashima Gulati,Aditi Sinha,Stanley C. Jordan,Pankaj Hari,Amit Kumar Dinda,Sonika Sharma,Rajendra N. Srivastava,Asha Moudgil,Arvind Bagga |
| Citations | 203 |
| DOI | 10.2215/cjn.03470410 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/2994081 |
| OpenAlex ID | https://openalex.org/W2118072881 |
| PMID | 20798255 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Ashima Gulati](https://scholariq.org/researchers/ashima-gulati/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.